中國醫療集團：截至二零二四年十二月三十一日止之年度報告.pdf

1、2024CHINA HEALTH GROUP INC.中國醫療集團有限公司(Carrying on business in Hong Kong as“萬全醫療集團”)(以 萬全醫療集團 名稱在香港經營業務)(Incorporated in the Cayman Islands with limited liability)(於 開 曼 群 島 註 冊 成 立 之 有 限 公 司)(Stock Code:08225)(股份代號:08225)ANNUAL REPORT FOR THEYEAR ENDED 31 DECEMBER 2024截至二零二四年十二月三十一日止之年度報告創業板被定位為一個旨在

2、容納中小企業的市場，與在交易所上市的其他公司相比，中小企業的投資風險可能更高。潛在投資者應意識到投資此類公司的潛在風險，並應在適當和仔細考慮後才作出投資決定。考慮到在創業板上市的公司一般都是中小企業，創業板上市的證券可能比主板上市的證券更容易受到市場高波動性的影響，而且不能保證創業板上市的證券會有流動性市場。香港交易所及結算有限公司及證券交易所對本檔的內容概不負責，對其準確性或完整性不作任何陳述，並明確聲明不對因本報告內容的全部或部分內容而產生的任何損失承擔任何責任。本公佈乃遵照聯交所創業板證券上市規則（創業板上市規則）之規定而提供有關中國醫療集團有限公司（本公司）之資料.中國醫療集團有限公司

3、各董事（董事）對此共同及個別地承擔全部責任.董事在作出一切合理查詢後確認,就彼等所知及深信：(1)本報告所載資料在各重大方面均為準確及完整,且並無誤導成份；(2)本報告並無遺漏其他事項致使本報告所載任何內容有所誤導；及(3)所有在本報告內表達之意見乃經過審慎周詳考慮後始行作出,並以公平合理之基準及假設為依據。CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED(THE“STOCK EXCHANGE”)香港聯合交易所有限公司（聯交所）創業板（創業板）之特色GEM has been positioned as a mar

4、ket designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange.Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after

5、due and careful consideration.Given that the companies listed on GEM are generally small and mid-sized companies,there is a risk that securities traded on GEM may be more susceptible to high market volatility than securities traded on the Main Board and no assurance is given that there will be a liq

6、uid market in the securities traded on GEM.Hong Kong Exchanges and Clearing Limited and the Stock Exchange take no responsibility for the contents of this report,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising f